Dermatology · Kew Gardens, NY
NPI
1689660565
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
10
Medicare group memberships
Hospitals
1
Hospital affiliations
8002 Kew Gardens Rd Ste 107
Kew Gardens, NY, 11415
Phone (718) 459-0900
Groups this clinician bills Medicare through
Medicare paid, 2024
$223K
3,048 services
Medicare patients, 2024
835
Average age 72
Drug cost, 2024
$5.2M
7,269 prescriptions
Company payments, 2025
$401K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey M Weinberg was code 99213 (office e&m - established), 603 times for 400 patients. In total Jeffrey M Weinberg billed 3,048 services in 50 codes, and Medicare paid $223K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 603 | 400 | $66.19 | $40K |
| 17003 Destruction Skin Lesion | Office | 426 | 66 | $5.16 | $2,200 |
| 99214 Office E&M - Established | Office | 417 | 230 | $101.26 | $42K |
| 17110 Destruction Skin Lesion | Office | 256 | 179 | $88.33 | $23K |
| 99203 Office E&M - New | Office | 208 | 208 | $83.57 | $17K |
| 17000 Destruction Skin Lesion | Office | 119 | 87 | $44.23 | $5,263 |
| 99204 Office E&M - New | Office | 94 | 94 | $124.41 | $12K |
| 11102 Skin Biopsy | Office | 90 | 86 | $61.87 | $5,568 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 22 | $0.76 | $42.54 |
| 11900 Skin | Office | 34 | 25 | $38.29 | $1,302 |
| 11103 Skin Biopsy | Office | 26 | 19 | $39.63 | $1,030 |
| 99212 Office E&M - Established | Office | 19 | 19 | $35.44 | $673 |
| 10040 Removal or Shaving of Skin Growth | Office | 19 | 18 | $76.20 | $1,448 |
By year: 2022 $456K for 7,319 services; 2023 $310K for 5,341 services; 2024 $223K for 3,048 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey M Weinberg prescribed most often to Medicare patients was Triamcinolone Acetonide, with 820 prescriptions and refills. In total Jeffrey M Weinberg wrote 7,269 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 820 | 938 | 417 | $12K |
| Ketoconazole Generic | 792 | 819 | 249 | $20K |
| Clobetasol Propionate Generic | 548 | 552 | 220 | $38K |
| Ammonium Lactate Generic | 529 | 563 | 236 | $12K |
| Tacrolimus Generic | 379 | 432 | 162 | $97K |
| Halobetasol Propionate Generic | 324 | 332 | 132 | $17K |
| Clindamycin Phosphate Generic | 287 | 304 | 124 | $13K |
| Mupirocin Generic | 242 | 242 | 133 | $1,487 |
| Tretinoin Generic | 223 | 242 | 101 | $20K |
| Mometasone Furoate Generic | 223 | 233 | 85 | $5,014 |
| Hydrocortisone Generic | 215 | 227 | 100 | $5,950 |
| Ciclopirox Ciclopirox Olamine | 212 | 262 | 82 | $7,304 |
| Minoxidil Generic | 208 | 250 | 44 | $2,687 |
| Dupixent Pen Dupilumab | 205 | 205 | 32 | $729K |
| Fluocinonide Generic | 184 | 203 | 59 | $17K |
Brand drugs: 1,229 claims; generic drugs: 6,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey M Weinberg $401K ($401K in general payments such as food, travel and fees) from 25 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $69K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 45 | $69K |
| Incyte Corporation INCY | 66 | $53K |
| Lilly USA, LLC LLY | 39 | $42K |
| Genzyme Corporation SNY | 40 | $31K |
| Janssen Biotech, Inc. JNJ | 32 | $30K |
| UCB, Inc. UCB.BR | 36 | $30K |
| Abbvie Inc. ABBV | 41 | $22K |
| Botanix SB Inc | 38 | $20K |
| Galderma Laboratories, L.P. GALD.SW | 19 | $20K |
| Pfizer Inc. PFE | 28 | $20K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.